Edwards Lifesciences | سود ناخالص در فروش



Gross Profit On Sales تغییر دادن تاریخ
Abbott USD 5.92B 114M 2025-03
AtriCure USD 92.63M 9K 2025-03
Baxter International USD 1.02B 19M 2024-12
Becton, Dickinson and Co. USD 2.26B 22M 2025-03
Boston Scientific USD 3.2B 97M 2025-03
Cooper Companies USD 660.2M 17.5M 2025-01
Dexcom USD 589M 120.3M 2025-03
Edwards Lifesciences USD 1.11B 17.5M 2025-03
Globus Medical USD 393.86M 38.67M 2024-12
Hologic USD 560.7M 19.8M 2025-03
ICU Medical USD 227.26M 22.41M 2024-12
Insulet USD 430.9M 53.8M 2024-12
Integra LifeSciences USD 265.84M 47.8M 2024-12
Intuitive Surgical USD 1.46B 184.5M 2025-03
J&J USD 14.6B 816M 2025-03
Masimo USD 244.7M 18.5M 2024-12
Medtronic USD 5.52B 49M 2025-01
Merit Medical Systems USD 172.02M 963K 2025-03
Stryker USD 3.81B 385M 2025-03
Tandem Diabetes Care USD 118.41M 39.05M 2025-03
Teleflex USD 389.44M 50.48M 2025-03
Zimmer Biomet Holdings USD 1.44B 150.9M 2024-12



Edwards Lifesciences سود ناخالص در فروش - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - May 2025.